Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
Clinical trial NCT04462328 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04462328
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2026-08-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.